Internal Medicine, Rheumatology · Clinton, MD
NPI
1003918558
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8926 Woodyard Rd, Suite #601
Clinton, MD, 20735
Phone (301) 856-1682
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
8,535 services
Medicare patients, 2024
490
Average age 73
Drug cost, 2024
$2.6M
2,827 prescriptions
Company payments, 2024
$1,182
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Roberson II was code J0897 (injection, denosumab, 1 mg), 2,760 times for 35 patients. In total James C Roberson II billed 8,535 services in 38 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 35 | $20.45 | $56K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,500 | 153 | $0.73 | $1,089 |
| 99214 Office E&M - Established | Office | 569 | 352 | $96.49 | $55K |
| 99213 Office E&M - Established | Office | 274 | 219 | $66.30 | $18K |
| 20610 Joint Injection | Office | 256 | 151 | $65.22 | $17K |
| 96372 Injection Administration | Office | 52 | 35 | $12.74 | $662 |
| 99204 Office E&M - New | Office | 24 | 24 | $104.20 | $2,501 |
| 99212 Office E&M - Established | Office | 21 | 21 | $45.30 | $951 |
By year: 2022 $323K for 13,221 services; 2023 $300K for 13,602 services; 2024 $212K for 8,535 services.
Medicare prescription drug claims, 2024
In 2024, the drug James C Roberson II prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 402 prescriptions and refills. In total James C Roberson II wrote 2,827 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 402 | 810 | 103 | $18K |
| Methotrexate Methotrexate Sodium | 262 | 595 | 73 | $9,023 |
| Prednisone Generic | 262 | 399 | 63 | $1,670 |
| Tramadol Hcl Generic | 115 | 117 | 28 | $957 |
| Gabapentin Generic | 107 | 157 | 31 | $1,511 |
| Meloxicam Generic | 100 | 128 | 21 | $490 |
| Diclofenac Sodium Generic | 97 | 139 | 30 | $4,253 |
| Leucovorin Calcium Generic | 92 | 210 | 25 | $5,692 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 88 | 88 | 19 | $2,553 |
| Cyclobenzaprine Hcl Generic | 85 | 99 | 20 | $1,098 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 83 | 87 | 19 | $3,222 |
| Humira(Cf) Pen Adalimumab | 74 | 102 | 13 | $712K |
| Celecoxib Generic | 71 | 122 | 20 | $2,238 |
| Tizanidine Hcl Generic | 51 | 79 | 14 | $846 |
| Alendronate Sodium Generic | 44 | 116 | 15 | $436 |
Brand drugs: - claims; generic drugs: 2,477 claims; opioid claims: 333.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid James C Roberson II $1,182 ($1,182 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $251.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $251 |
| Abbvie Inc. ABBV | 14 | $225 |
| UCB, Inc. UCB.BR | 11 | $166 |
| Amgen Inc. AMGN | 8 | $148 |
| GlaxoSmithKline, LLC. GSK | 4 | $93.25 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $83.55 |
| Lilly USA, LLC LLY | 3 | $70.28 |
| Pfizer Inc. PFE | 3 | $62.69 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $57.72 |
| Genzyme Corporation SNY | 1 | $24.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.